Mesa Laboratories is a high-barrier, recurring-revenue life sciences platform trading at a transition-driven discount, with resilient sterilization and calibration franchises offsetting near-term biopharma and China genomics volatility.
Overview
Mesa Laboratories is a specialized life sciences tools and quality-control platform serving highly regulated pharmaceutical, biotech, hospital, medical device, clinical lab, and dialysis markets. Its four segments combine capital equipment placements with high-margin recurring consumables and services, which represent roughly 75% of revenue. The company benefits from mission-critical workflows, FDA/EMA compliance mandates, strong niche brands, and high switching costs tied to regulatory re-validation. Geographic exposure is balanced across North America and Europe, with limited but challenged China exposure. Mesa offers a defensive, high-barrier platform currently navigating operational transition.